Global  

Trusted News Discovery Since 2008
One News Page
One News Page > News Videos > Food and Drug Administration > FDA Grants Accelerated Approval For Bladder Cancer Drug

FDA Grants Accelerated Approval For Bladder Cancer Drug

Video Credit: Wochit News - Duration: 00:43s - Published < > Embed
FDA Grants Accelerated Approval For Bladder Cancer Drug

FDA Grants Accelerated Approval For Bladder Cancer Drug

Padcev is the first FDA approved treatment in the US for patients with advanced or metastatic urothelial cancer.

The drug will treat patients with advanced bladder cancer, reports Reuters.

It is for when the disease has progressed even after immunotherapy and chemotherapy.

The American Cancer Society estimates 17,670 people will die from bladder cancer in the US this year.

The continued approval of the drug may depend upon verification of clinical benefit in confirmatory trials.

0
shares
ShareTweetSavePostSend
 

You Might Like


Tweets about this


Recent related videos from verified sources

What are the Current Cancer Drug Therapies [Video]What are the Current Cancer Drug Therapies

Dr. Sunil Verma, MD, MSEd, FRCPC, Oncologist, discusses current cancer drug therapies.

Credit: HealthChoicesFirst     Duration: 02:28Published

FDA Issues Warning: Stay Away From Deadly 'Cancer Cure' Supplements [Video]FDA Issues Warning: Stay Away From Deadly 'Cancer Cure' Supplements

The Food and Drug Administration has issued a public health alert for dietary supplements containing cesium salts. These products usually contain a specific formulation known as cesium chloride...

Credit: Wochit News     Duration: 00:40Published

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.